Global Allergy Diagnostics Market Overview (2021–2031)

Market Size and Growth

The global allergy diagnostics market was valued at approximately $5 billion in 2021. It is forecasted to reach around $16.7 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2031. Recent estimates for the current decade point to continued strong growth, supported by escalating allergic disease prevalence, advances in diagnostic technology, and heightened awareness of allergy management worldwide.

What Are Allergies and Diagnostic Techniques?

Allergies are hypersensitive immune reactions to typically harmless substances called allergens (e.g., pollen, dust mites, pet dander, foods, and drugs).

Diagnostic tests determine allergy type and inform treatment. Major techniques include:

Blood tests (e.g., IgE tests, ELISA, RAST)

Skin prick tests

Patch tests

Intradermal tests

Challenge tests

Market Drivers

Rising Environmental Pollution: Urbanization and air pollution heighten allergy risks, especially respiratory and skin allergies. Urban residents face greater exposure and thus higher prevalence than rural populations.

Increase in Food Allergies: Food allergy rates are rising, particularly in highly urbanized, developed regions, pushing demand for advanced diagnostics.

Climate Change & Hygiene Hypothesis: Modern cleanliness and early-life infection exposure patterns impact immune system development, potentially increasing allergy prevalence.

Technological Advancements: New biosensors, wireless devices, mobile health (mHealth), and at-home test kits are broadening market accessibility and penetration.

Healthcare Infrastructure & Awareness: Better healthcare access, especially in North America and Asia-Pacific, supports diagnostic market expansion.

Market Challenges

High Instrument and Operating Costs: Advanced analyzers (e.g., luminometers: $3,000–$14,000; immunoassay analyzers: $10,000–$20,000), maintenance, and staffing overheads make adoption difficult for smaller clinics and labs.

Limited mHealth Solutions: mHealth apps and point-of-care devices for allergy diagnostics are emerging, but widespread adoption is constrained by a paucity of validated solutions for conditions like Allergic Rhinitis.

Market Segmentation

By Test Type

Segment Share & Growth Key Features

In Vivo Largest share (skin/challenge tests) Reliable, practical, economical; detects hypersensitivity

In Vitro Fastest projected growth IgE antibody tests; compatible with various skin conditions

By Product & Service

Segment Share & Growth Drivers

Consumables Dominant segment Driven by test volume and frequent re-stocking

Instruments Significant Includes analyzers and automated diagnostic systems

Services Support role Lab services, result interpretation, consultations

By Allergen Type

Allergen Type Market Position Examples

Inhaled Allergens Largest segment (~43%) Pollen, dust mites, mold, pet dander

Food Allergens Significant growth Peanuts, nuts, shellfish, dairy

Drug Allergens Substantial need Antibiotics, NSAIDs, chemotherapy

Others Includes insect, latex

By End-User

End User Market Share & Growth Drivers

Diagnostic Laboratories Largest & fastest growth Independent labs, specialized accuracy

Hospital Labs Major share High test volumes, capital expenditures

Academic Institutes Niche Research and teaching functions

Others Small offices, clinics Limited by cost barriers

By Region

Region 2021 Leader Growth Factors

North America Top region High allergy prevalence, advanced infrastructure, tech

Europe Large share Public awareness, favorable policies

Asia-Pacific Fastest CAGR Urban population, rising pollution, emerging demand

LAMEA Growing Investment in healthcare, increased awareness

Key Players

Notable industry leaders include:

Thermo Fisher Scientific

PerkinElmer Inc.

Danaher Corporation

Hitachi Chemicals

BIOMÉRIEUX

Omega Diagnostics Group PLC

Siemens Healthineers

Eurofins Scientific

Stallergenes Greer

Neogen Corporation

These companies drive innovation via new product launches, strategic partnerships, and technological upgrades—particularly in multiplex testing platforms and digital diagnostics.

Future Outlook

The allergy diagnostics market is poised for robust growth fueled by:

Rising allergic disease prevalence, pollution, and changing urban lifestyles.

Ongoing technological enhancement, such as advanced biosensors, AI-driven diagnostics, and telemedicine integration.

Strong demand for quick, reliable, and accessible testing, especially in emerging markets.

https://www.alliedmarketresearch.com/allergy-diagnostic-market